These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 178800)

  • 1. Heterologous sera: a target for in vitro cell-mediated cytotoxicity.
    Forni G; Green I
    J Immunol; 1976 Jun; 116(6):1561-5. PubMed ID: 178800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
    Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
    Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor rejection mediated by an amphotropic murine leukemia virus.
    Zbar B; Nagai A; Terata N; Hovis J
    Cancer Res; 1983 Jan; 43(1):46-53. PubMed ID: 6182993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The attacker: target-cell ratio and serum effects on in vitro cell-mediated immunity.
    Mantovani A; Veechi A; Spreafico F
    J Natl Cancer Inst; 1975 Aug; 55(2):483-4. PubMed ID: 1159829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M; Herberman R; Gorelik E
    Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody.
    Prather SO; Lausch RN
    J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterophile antibodies in the sera from renal transplant recipients.
    Akiyama N; Mori T; Kusaba R; Inou T; Kawamura A
    Jpn J Exp Med; 1978 Dec; 48(6):519-24. PubMed ID: 374802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity: an assay using 125 I-iododeoxyuridine-labeled target cells.
    Cohen AM; Burdick JF; Ketcham AS
    J Immunol; 1971 Sep; 107(3):895-8. PubMed ID: 5572095
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced immunogenicity of the cultured rat fibrosarcoma KMT-17 by cultivation in a low concentration of fetal calf serum.
    Chiba I; Oikawa T; Naiki M; Takimoto M; Miyoshi I; Mizuno S; Yamashina K; Yamagiwa S; Kobayashi H
    Cancer Res; 1987 Apr; 47(7):1815-9. PubMed ID: 3815375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis.
    Begovic M; Herberman RB; Gorelik E
    Nat Immun; 1993; 12(4-5):250-66. PubMed ID: 8257830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic antigens shared between chemically induced lymphosarcomas and fibrosarcomas of the mouse.
    Ménard S; Colnaghi MI
    J Natl Cancer Inst; 1975 Feb; 54(2):479-81. PubMed ID: 1172784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune response to syngeneic UV-induced tumors. III. Requirement for an Ia+ macrophage in the in vitro differentiation of cytotoxic T lymphocytes.
    Woodward JG; Fernandez PA; Daynes RA
    J Immunol; 1979 Apr; 122(4):1196-202. PubMed ID: 312833
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Goat serum: an alternative to fetal bovine serum in biomedical research.
    Paranjape S
    Indian J Exp Biol; 2004 Jan; 42(1):26-35. PubMed ID: 15274477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.